A
Armando Santoro
Researcher at Humanitas University
Publications - 961
Citations - 56759
Armando Santoro is an academic researcher from Humanitas University. The author has contributed to research in topics: Medicine & Cancer. The author has an hindex of 93, co-authored 847 publications receiving 48505 citations. Previous affiliations of Armando Santoro include Aix-Marseille University & University of Milan.
Papers
More filters
Journal ArticleDOI
Adjuvant treatment of high-risk, radically resected gastric cancer patients with 5-fluorouracil, leucovorin, cisplatin, and epidoxorubicin in a randomized controlled trial
Stefano Cascinu,Roberto Labianca,Carlo Barone,Armando Santoro,Carlo Carnaghi,Alessandra Cassano,Giordano D. Beretta,Vincenzo Catalano,Oscar Bertetto,Sandro Barni,Luciano Frontini,Enrico Aitini,Silvia Rota,Valter Torri,Irene Floriani +14 more
TL;DR: The extent of toxicity experienced by the patients in the adjuvant setting suggests that, in gastric cancer, chemotherapy may be more safely administered preoperatively.
Journal ArticleDOI
Phase Ib study of NGR–hTNF, a selective vascular targeting agent, administered at low doses in combination with doxorubicin to patients with advanced solid tumours
Vanesa Gregorc,Armando Santoro,E Bennicelli,C.J.A. Punt,Giovanni Citterio,Johanna N. H. Timmer-Bonte,F. Caligaris Cappio,Antonio Lambiase,Claudio Bordignon,C.M.L. van Herpen +9 more
TL;DR: NGR–hTNF plus doxorubicin was administered safely and showed promising activity in patients pre-treated with anthracyclines and was selected for phase II development.
Journal ArticleDOI
An international expanded-access programme of everolimus: Addressing safety and efficacy in patients with metastatic renal cell carcinoma who progress after initial vascular endothelial growth factor receptor-tyrosine kinase inhibitor therapy
Viktor Grünwald,Pierre I. Karakiewicz,Sevil Bavbek,Kurt Miller,Jean-Pascal Machiels,Se-Hoon Lee,James Larkin,Petri Bono,Sun Young Rha,Daniel Castellano,Christian U. Blank,Jennifer J. Knox,Robert E. Hawkins,Oezlem Anak,Marianne Rosamilia,Jocelyn Booth,Nicoletta Pirotta,Istvan Bodrogi,M. Romedi,S. Ferrandini,M. Rondinon,K. Pittman,David Goldstein,J. Shapiro,S. Troon,Desmond Yip,Paul N. Mainwaring,R. Zigeuner,W. Loidl,Richard Greil,Manuela Schmidinger,J. De Greve,Sylvie Rottey,Jan B. Vermorken,J-P. Machiels,Thierry Gil,Christine Gennigens,Thierry Roumeguere,Carlos H. Barrios,C. Mathias,Hazem I. Assi,Sebastien J. Hotte,P. Karakiewicz,Jennifer J. Knox,S. Spadafora,Lori Wood,Pawel Zalewski,M. Mackensie,G. A. Bjarnason,A. Lalancette,A. Chan,B. Higgins,Scott North,Denis Soulières,J. Asselah,C. Sperlich,Wilson H. Miller,S. K. Yadav,Robert Hassan El-Maraghi,J. Godoy,Jana Prausová,J. Katolicka,L. Petruzelka,I. Kiss,P. Bono,M. Lapela,K. Miller,L. Bergmann,J. Beck,Elke Jäger,M. Kindler,Friedrich Overkamp,Manfred P. Wirth,W. Hölzer,Juergen E. Gschwend,Arnulf Stenzl,Thomas Gauler,D. Niederwieser,Norbert Marschner,A. Lück,H. Tessen,C. Eichelberg,T. Steiner,P. Goebell,E. Kettner,A. Bakhshandeh-Bath,M. Wilhelm,Sandra Schmitz,A. Jacob,S. Bierer,U. Kube,Michael Staehler,E. Engel,M. Frambach,U. Schellenberger,Peter Albers,Jean-Paul Simon,M. Gleissler,T. Klotz,Roland Repp,H. Kröning,J. Westermann,U. Rebmann,B. Brehmer,N. Niederle,C. Grund,K. Verpoort,P. Fonara,J. Rassweiler,Aristotle Bamias,George Fountzilas,E. Razis,D. Mouratidou,Vassilis Georgoulias,E. Samantas,I. Bodrogi,L. Mangel,János Szántó,R. Berger,Avivit Peer,Avishay Sella,R. Ben-Yosef,H. Nechushtan,L. Crinò,Sergio Bracarda,Libero Ciuffreda,C. Graiff,Alfredo Falcone,Mario Roselli,Cora N. Sternberg,Armando Santoro,Enzo Maria Ruggeri,Alessandra Bearz,M. Venturini,Massimo Aglietta,Dino Amadori,F. Di Costanzo,Maria Giovanna di Bari,Nicola Gebbia,Pf Conte,Andrea Bonetti,Roberto Bordonaro,Stefano Cascinu,A. Contu,Giorgio Cruciani,Donatello Gasparro,Matteo Nardi,G. Lelli,G. Lo Re,Francesco Boccardo,Vito Lorusso,Evaristo Maiello,P. Manente,Rodolfo Passalacqua,Francovito Piantedosi,Camillo Porta,Cosimo Sacco,Carlo Tondini,S. De Placido,Giacomo Cartenì,L. Dogliotto,Giovanni Rosti,M. Milella,F. Roila,Domenico Amoroso,Gabriella Farina,H. Al-Khatib,S. Lee,T. Kim,J. Ahn,H. Lim,S. Rha,I. Chung,J. Kim,J. Chung,Marwan Ghosn,A. Shameseddine,R. Lugo,P. Cabrera,Susanne Osanto,G. Groenewegen,C. Blank,F. van den Eertwegh,C.M.L. van Herpen,Sjoukje F. Oosting,Patricia M. M. B. Soetekouw,Wolfgang Lilleby,O. Klepp,T. Guren,Juan Carlos Alcedo,Petr Alexandrovich Karlov,Dmitry Nosov,L. Roman,I. Rusakov,Shouki Bazarbashi,C. Toh,Jozef Mardiak,M. Constenla,F. Garcia del Muro Solans,J. Maroto Ray,J. Bellmunt Mollins,D. Castellano,I. Duran Martinez,B. Mellado Gonzalez,M. Domenech Santasusana,M. Lopez-Brea Piqueras,J. Campillo Fuentes,J. Gonzalez Larriba,R. Luque Caro,A. Meana Garcia,L. Aparicio,N. Batista Lopez,V. Calderero Aragon,C. Valverde Morales,M. Figueiras,J. Contreras Ibanez,E. Gonzalez Billalabeitia,E. Estrada,J. Arranz,J. Lambea Sorrosal,A. Lozano,M. Codes de Villena,Enrique Espinosa,R. Lopez,J.M. Perez Garcia,A. Laurell,U. Stierner,M. Cwikiel,M. Borner,P. Y. Dietrich,Christian Rothermundt,Y. Pu,Y. Chang,Y. Ou,C. Chuang,Y. Liao,V. Srimuninnimit,V. Sriuranpong,Suleyman Buyukberber,B. Yalcin,E. Goker,S Songül Yalçin,T. Geldart,John Wagstaff,Steve Nicholson,S. Chowdhury,Amit Bahl,Robert Jones,A. Azzabi,D. Chao,Kate Fife,R. Hawkins,G. Mead,Paul Nathan,Hardev Pandha,Julio Hajdenberg,Nashat Y. Gabrail,N. Nimeh,T. Logan,Thomas W. Flaig,R. Schraeder,Brian I. Rini,M. O'Rourke,C. Alemany,A. Kessinger,Asim Amin,M. Arriaga,J. Rodriguez +267 more
TL;DR: Everolimus is well tolerated in patients with mRCC and demonstrates a favourable risk-benefit ratio and safety findings and tumour responses were consistent with those observed in RECORD-1.
Journal ArticleDOI
Second-line chemotherapy in malignant pleural mesothelioma: results of a retrospective multicenter survey.
Paolo Andrea Zucali,Matteo Simonelli,G. Michetti,Marcello Tiseo,Giovanni Luca Ceresoli,Elena Collovà,Alessandro Follador,M. Lo Dico,Anna Moretti,F. De Vincenzo,Elena Lorenzi,Matteo Perrino,Laura Giordano,Gabriella Farina,Armando Santoro,Marina Chiara Garassino +15 more
TL;DR: SL-chemotherapy seems to be active in MPM-patients, particularly in younger patients with ECOG-PS0 and prolonged TTP after FL-pemetrexed-based chemotherapy.
Journal ArticleDOI
Vinorelbine: An active drug for the management of patients with heavily pretreated Hodgkin's disease
Liliana Devizzi,Armando Santoro,Valeria Bonfante,Simonetta Viviani,L. Balzarini,P. Valagussa,G. Bonadonna +6 more
TL;DR: The data indicate that vinorelbine is active as a single agent in heavily pretreated patients with Hodgkin's disease and suggests a possible absence of cross-resistance between vinORElbine and other vinka analogs.